Higher risks for spontaneous pregnancy loss and congenital anomalies seen in association with exposure to preconception CT
WEDNESDAY, Sept. 10, 2025 (HealthDay News) — Exposure to preconception computed tomography (CT) imaging is associated with a higher risk for spontaneous pregnancy loss and congenital anomalies, according to a study published online Sept. 9 in the Annals of Internal Medicine.
In a population-based observational study, Camille Simard, M.D., from the Jewish General Hospital and Lady Davis Institute for Medical Research in Montreal, and colleagues examined the risk for spontaneous pregnancy loss and congenital anomalies in offspring of women exposed to CT ionizing radiation before conception. The study included 5,142,339 recognized pregnancies and 3,451,968 live births identified between 1992 and 2023.
The researchers found that those exposed to CT imaging more often had diabetes, hypertension, obesity, and smoking. The rates of spontaneous pregnancy loss among recognized pregnancies were 101, 117, 130, and 142 per 1,000 pregnancies with zero, one, two, and three or more preconception CT scans, respectively, with adjusted hazard ratios of 1.08, 1.14, and 1.19 for one, two, and three or more CT scans, respectively. The rates of congenital anomalies among live births were 62, 84, 96, and 105 per 1,000 births in those with zero, one, two, and three or more CT scans, with adjusted hazard ratios of 1,06, 1.11, and 1.15 for one, two, and three or more CT scans, respectively. For head CT, the risk was not consistently lower than that for CT of the abdomen, pelvis, or lower spine.
“In young women, alternative imaging methods to CT should be considered, when appropriate,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects
Antenatal Complications Increased With Maternal Multiple Long-Term Conditions
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders
Dose-Dependent Link Seen for Clomiphene Citrate, Adverse Perinatal Outcomes
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors